16 HOW SUPPLIED/STORAGE AND HANDLING
Cisatracurium Besylate Injection, USP is a clear solution supplied as follows:
Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1098-02 | 10 mg/5 mL |
Carton containing 10 Single-dose Vials | (2 mg/mL) |
NDC 0409-1208-01 | 20 mg/10 mL |
Carton containing 10 Multiple-dose Vials | (2 mg/mL) |
NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].
Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1103-01 | 200 mg/20 mL |
Carton containing 10 Single-dose Vials | (10 mg/mL) |
Intended only for use in the ICU.
Discard unused portion of the 5 mL and 20 mL single-dose vials.
Storage
Cisatracurium Besylate Injection, USP should be refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.